Shoko Matsui

10.1k total citations · 1 hit paper
98 papers, 1.9k citations indexed

About

Shoko Matsui is a scholar working on Epidemiology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shoko Matsui has authored 98 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 36 papers in Rheumatology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shoko Matsui's work include IgG4-Related and Inflammatory Diseases (32 papers), Neuroendocrine Tumor Research Advances (29 papers) and Gastrointestinal disorders and treatments (15 papers). Shoko Matsui is often cited by papers focused on IgG4-Related and Inflammatory Diseases (32 papers), Neuroendocrine Tumor Research Advances (29 papers) and Gastrointestinal disorders and treatments (15 papers). Shoko Matsui collaborates with scholars based in Japan, United States and Spain. Shoko Matsui's co-authors include Ryuji Hayashi, Mitsuhiro Kawano, Hiroki Takahashi, Shigeyuki Kawa, C. Yamamoto, Yasuharu Sato, Hisanori Umehara, Masashi Kobayashi, Takashi Akamizu and Hiroshi Gotô and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Shoko Matsui

94 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD

2020 276 citations Shoko Matsui, Mitsuhiro Kawano et al. profile →

Peers

Shoko Matsui

RHEUM

EPIDE

SURGE

PRM

Tomoyuki Nomura Japan

Caspar Grond‐Ginsbach Germany

Yuji Kato Japan

Robert W. McMurray United States

Ken Kawabe Japan

Yasuhiro Hosoda Japan

Yuji Nakamaru Japan

Leah C. Kottyan United States

Kenji Mitsumori Japan

Guangliang Jiang China

Tomoyuki Nomura Japan

Shoko Matsui

342 ×0.4

RHEUM

361 ×0.5

EPIDE

853 ×1.3

SURGE

344 ×0.9

212 ×0.8

PRM

Citations per year, relative to Shoko Matsui Shoko Matsui (= 1×) peers Tomoyuki Nomura

Countries citing papers authored by Shoko Matsui

Since Specialization

Citations

This map shows the geographic impact of Shoko Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoko Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoko Matsui more than expected).

Fields of papers citing papers by Shoko Matsui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoko Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoko Matsui. The network helps show where Shoko Matsui may publish in the future.

Co-authorship network of co-authors of Shoko Matsui

This figure shows the co-authorship network connecting the top 25 collaborators of Shoko Matsui. A scholar is included among the top collaborators of Shoko Matsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoko Matsui. Shoko Matsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inomata, Minehiko, Naoki Takata, Seisuke Okazawa, et al.. (2023). Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer. Scientific Reports. 13(1). 10807–10807. 10 indexed citations

Handa, Tomohiro, Shoko Matsui, Hiroshi Yamamoto, et al.. (2023). The 2022 revised diagnostic criteria for IgG4-related respiratory diseases. Respiratory Investigation. 61(6). 755–759.

Mizushima, Ichiro, Takako Saeki, Daisuke Kobayashi, et al.. (2023). Improved Renal Function in Initial Treatment Improves Patient Survival, Renal Outcomes, and Glucocorticoid-Related Complications in IgG4-Related Kidney Disease in Japan. Kidney International Reports. 9(1). 52–63. 2 indexed citations

Matsui, Shoko. (2022). III. IgG4-related Respiratory Disease. Nihon Naika Gakkai Zasshi. 111(10). 2094–2101.

Inomata, Minehiko, Seisuke Okazawa, Kenta Kambara, et al.. (2022). Association of Tumor PD-L1 Expression With Time on Treatment Using EGFR-TKIs in Patients With EGFR-Mutant Non-small Cell Lung Cancer. Cancer Diagnosis & Prognosis. 2(3). 324–329. 7 indexed citations

Waseda, Yuko, Kazunori Yamada, Kiyoaki Ito, et al.. (2021). The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease. PLoS ONE. 16(3). e0247173–e0247173. 4 indexed citations

Takata, Naoki, Seisuke Okazawa, Kenta Kambara, et al.. (2020). Irinotecan monotherapy as third- or further-line treatment for patients with small cell lung cancer. Tumori Journal. 107(6). 536–541. 2 indexed citations

Inomata, Minehiko, Naoki Takata, Seisuke Okazawa, et al.. (2020). Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy. Diagnostics. 10(12). 1006–1006. 13 indexed citations

Yamamoto, Hiroshi, Masanori Yasuo, Masamichi Komatsu, et al.. (2019). Comparison of the chemokine profiles in the bronchoalveolar lavage fluid between IgG4-related respiratory disease and sarcoidosis: CC-chemokine ligand 1 might be involved in the pathogenesis of sarcoidosis. Cytokine. 120. 125–129. 2 indexed citations

10.

Inomata, Minehiko, Seisuke Okazawa, Shingo Imanishi, et al.. (2019). Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor. Anticancer Research. 39(12). 6887–6893. 26 indexed citations

11.

Hayashi, Ryuji, Seisuke Okazawa, Kenta Kambara, et al.. (2017). SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients. International Journal of COPD. Volume 12. 3237–3244. 19 indexed citations

12.

Inomata, Minehiko, Ryuji Hayashi, Seisuke Okazawa, et al.. (2015). Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib. Molecular and Clinical Oncology. 3(4). 802–806. 12 indexed citations

13.

Ichikawa, Tomomi, Ryuji Hayashi, Kensuke Suzuki, et al.. (2012). Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin‐induced mouse model of asthma. Respirology. 18(2). 332–339. 71 indexed citations

14.

Maruyama, Muneharu, Toru Yamada, Ryuji Hayashi, et al.. (2005). Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. International Journal of Cancer. 117(1). 21–31. 38 indexed citations

15.

Hayashi, Ryuji, Naohiro Yamashita, Shoko Matsui, et al.. (2000). Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. European Respiratory Journal. 16(3). 452–452. 83 indexed citations

16.

Matsui, Shoko, Naohiro Yamashita, Hirofumi Taki, et al.. (1999). Role of the endogenous prostaglandin E2 in human lung fibroblast interleukin-11 production. Respiratory Medicine. 93(9). 637–642. 7 indexed citations

17.

Wen, Longping, et al.. (1996). Airway epithelial cells produce stem cell factor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1314(3). 183–186. 37 indexed citations

18.

Matsui, Shoko, Toshiomi Okuno, & Kimíyasu Shiraki. (1994). Functional Roles of Terminal Glycomoieties in Varicella-Zoster Virus Infection. Virology. 198(1). 50–58. 12 indexed citations

19.

Ochiai, Hiroshi, et al.. (1992). Infection enhancement of influenza A NWS virus in primary murine macrophages by anti‐hemagglutinin monoclonal antibody. Journal of Medical Virology. 36(3). 217–221. 53 indexed citations

20.

Aoki, Hiroki, Toyonori Tsuzuki, Osamu Yamaguchi, et al.. (1990). Clinical Studies on the Effectiveness of Prazosin HCl (Minipress® Tablets) in the Treatment of Dysuria Accompanying Benign Prostatic Hyperplasia. Urologia Internationalis. 45(1). 18–25. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact